Real-World Health Outcomes of Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Glargine 100 U/mL (Gla-100) in Patients with Type 1 (T1D) and Type 2 Diabetes (T2D) in the Canadian LMC Diabetes Patient Registry—The REALITY Study

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1052-P
Author(s):  
ALEXANDER ABITBOL ◽  
RUTH E. BROWN ◽  
DISHAY JIANDANI ◽  
LUC SAURIOL ◽  
RONNIE ARONSON
Keyword(s):  
Type 2 Diabetes ◽  
Health Outcomes ◽  
Insulin Glargine ◽  
Real World ◽  
Diabetes Patient ◽  
World Health ◽  
Patient Registry

Switching to Insulin Degludec from Insulin Glargine U100 Improves Glycemic Control in People with Type 1 (T1D) or Type 2 diabetes (T2D) in a Real-World Setting

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1014-P
Author(s):  
SOREN T. KNUDSEN ◽  
NIKOLAOS TENTOLOURIS ◽  
BERND SCHULTES ◽  
ANNUNZIATA LAPOLLA ◽  
MARKUS EIDENMUELLER ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Insulin Glargine ◽  
Real World ◽  
Insulin Degludec ◽  
Real World Setting

126-LB: Glycemic Outcomes for People with Type 1 and Type 2 Diabetes Using Control-IQ Technology: Real-World Data from Early Adopters

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 126-LB ◽  
Author(s):  
STEPHANIE HABIF ◽  
ALEXANDRA CONSTANTIN ◽  
LARS MUELLER ◽  
HARSIMRAN SINGH
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Real World Data ◽  
Early Adopters ◽  
World Data ◽  
Glycemic Outcomes

2327-PUB: Real-World Patient-Reported Outcomes (PROs) with Insulin Glargine 300 U/ml (Gla-300) in Basal Bolus-Treated People with Type 2 Diabetes (T2DM): The MAGE Study

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2327-PUB ◽  
Author(s):  
ANN A. VERHAEGEN ◽  
ANDRÉ SCHEEN ◽  
KATHY C. ALEXANDRE ◽  
JACQUES BRUHWYLER ◽  
IDES M. COLIN
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Real World ◽  
Patient Reported Outcomes ◽  
Patient Reported ◽  
Basal Bolus
Sign in / Sign up

Export Citation Format

Share Document